Literature DB >> 17687034

Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities.

Cheng Wang1, Ruifeng Lu, Xuezhi Ouyang, Michelle W L Ho, William Chia, Fengwei Yu, Kah-Leong Lim.   

Abstract

Mutations in the parkin gene are a predominant cause of familial parkinsonism. Although initially described as a recessive disorder, emerging evidence suggest that single parkin mutations alone may confer increased susceptibility to Parkinson's disease. To better understand the effects of parkin mutations in vivo, we generated transgenic Drosophila overexpressing two human parkin missense mutants, R275W and G328E. Transgenic flies that overexpress R275W, but not wild-type or G328E, human parkin display an age-dependent degeneration of specific dopaminergic neuronal clusters and concomitant locomotor deficits that accelerate with age or in response to rotenone treatment. Furthermore, R275W mutant flies also exhibit prominent mitochondrial abnormalities in their flight muscles. Interestingly, these defects caused by the expression of human R275W parkin are highly similar to those triggered by the loss of endogenous parkin in parkin null flies. Together, our results provide the first in vivo evidence demonstrating that parkin R275W mutant expression mediates pathogenic outcomes and suggest the interesting possibility that select parkin mutations may directly exert neurotoxicity in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17687034      PMCID: PMC6672933          DOI: 10.1523/JNEUROSCI.0218-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  31 in total

1.  Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.

Authors:  R Hilker; C Klein; M Ghaemi; B Kis; T Strotmann; L J Ozelius; O Lenz; P Vieregge; K Herholz; W D Heiss; P P Pramstaller
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

2.  Association between early-onset Parkinson's disease and mutations in the parkin gene.

Authors:  C B Lücking; A Dürr; V Bonifati; J Vaughan; G De Michele; T Gasser; B S Harhangi; G Meco; P Denèfle; N W Wood; Y Agid; A Brice
Journal:  N Engl J Med       Date:  2000-05-25       Impact factor: 91.245

Review 3.  Neurodegeneration: how does parkin prevent Parkinson's disease?

Authors:  Mark R Cookson
Journal:  Curr Biol       Date:  2003-07-01       Impact factor: 10.834

4.  Parkin: a multipurpose neuroprotective agent?

Authors:  Mel B Feany; Leo J Pallanck
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

5.  The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans.

Authors:  Rüdiger Hilker; Christine Klein; Katja Hedrich; Laurie J Ozelius; Peter Vieregge; Karl Herholz; Peter P Pramstaller; Wolf Dieter Heiss
Journal:  Neurosci Lett       Date:  2002-04-19       Impact factor: 3.046

Review 6.  Modelling neurodegenerative diseases in Drosophila: a fruitful approach?

Authors:  Miratul M K Muqit; Mel B Feany
Journal:  Nat Rev Neurosci       Date:  2002-03       Impact factor: 34.870

7.  Functional association of the parkin gene promoter with idiopathic Parkinson's disease.

Authors:  Andrew B West; Demetrius Maraganore; Julia Crook; Tim Lesnick; Paul J Lockhart; Kristen M Wilkes; Gregory Kapatos; John A Hardy; Matt J Farrer
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

8.  Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.

Authors:  Jessica C Greene; Alexander J Whitworth; Isabella Kuo; Laurie A Andrews; Mel B Feany; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

9.  Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.

Authors:  Sofia A Oliveira; William K Scott; Eden R Martin; Martha A Nance; Ray L Watts; Jean P Hubble; William C Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; William G Ondo; Fred H Allen; Burton L Scott; Christopher G Goetz; Gary W Small; Frank Mastaglia; Jeffrey M Stajich; Fengyu Zhang; Michael W Booze; Michelle P Winn; Lefkos T Middleton; Jonathan L Haines; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

10.  Complex relationship between Parkin mutations and Parkinson disease.

Authors:  Andrew West; Magali Periquet; Sarah Lincoln; Christoph B Lücking; David Nicholl; Vincenzo Bonifati; Nina Rawal; Thomas Gasser; Ebba Lohmann; Jean-François Deleuze; Demetrius Maraganore; Allan Levey; Nick Wood; Alexandra Dürr; John Hardy; Alexis Brice; Matt Farrer
Journal:  Am J Med Genet       Date:  2002-07-08
View more
  44 in total

Review 1.  Recent advances in using Drosophila to model neurodegenerative diseases.

Authors:  Bingwei Lu
Journal:  Apoptosis       Date:  2009-08       Impact factor: 4.677

2.  Mitochondrial therapies for Parkinson's disease.

Authors:  Bobby Thomas; M Flint Beal
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

3.  α-Arbutin Protects Against Parkinson's Disease-Associated Mitochondrial Dysfunction In Vitro and In Vivo.

Authors:  Yaqi Ding; Deqin Kong; Tong Zhou; Nai-di Yang; Chenqi Xin; Jiajia Xu; Qi Wang; Hang Zhang; Qiong Wu; Xiaomei Lu; Kahleong Lim; Bo Ma; Chengwu Zhang; Lin Li; Wei Huang
Journal:  Neuromolecular Med       Date:  2019-08-10       Impact factor: 3.843

4.  Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy.

Authors:  Jonathan P Bernardini; Jason M Brouwer; Iris Kl Tan; Jarrod J Sandow; Shuai Huang; Che A Stafford; Aleksandra Bankovacki; Christopher D Riffkin; Ahmad Z Wardak; Peter E Czabotar; Michael Lazarou; Grant Dewson
Journal:  EMBO J       Date:  2018-12-20       Impact factor: 11.598

Review 5.  RNA metabolism in the pathogenesis of Parkinson׳s disease.

Authors:  Bingwei Lu; Stephan Gehrke; Zhihao Wu
Journal:  Brain Res       Date:  2014-03-13       Impact factor: 3.252

6.  The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy.

Authors:  Baris Bingol; Joy S Tea; Lilian Phu; Mike Reichelt; Corey E Bakalarski; Qinghua Song; Oded Foreman; Donald S Kirkpatrick; Morgan Sheng
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

Review 7.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

8.  Life span and locomotor activity modification by glucose and polyphenols in Drosophila melanogaster chronically exposed to oxidative stress-stimuli: implications in Parkinson's disease.

Authors:  Hector Flavio Ortega-Arellano; Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  Neurochem Res       Date:  2011-03-26       Impact factor: 3.996

9.  Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.

Authors:  J Brooks; J Ding; J Simon-Sanchez; C Paisan-Ruiz; A B Singleton; S W Scholz
Journal:  J Med Genet       Date:  2009-04-06       Impact factor: 6.318

10.  The effects of polyphenols on survival and locomotor activity in Drosophila melanogaster exposed to iron and paraquat.

Authors:  M Jimenez-Del-Rio; C Guzman-Martinez; C Velez-Pardo
Journal:  Neurochem Res       Date:  2009-08-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.